Thailand’s Public Health Minister Asked To Step Down For Failing To Report Shareholdings
This article was originally published in PharmAsia News
PERTH, Australia - Thailand's Public Health Minister Chaiya Sasomsab may have to step down from his post after failing to report his wife's shareholdings in a company, according to the Bangkok Post
You may also be interested in...
Thailand's drug authority says it intends to use its compulsory licensing policy to import a generic of the Sanofi Aventis breast cancer drug Taxotere (docetaxel). The Government Pharmaceutical Organisation says it also will follow through on plans to use its CL policy to import two other cancer generics, for Roche/OSI Pharmaceuticals' Tarceva (erlotinib hydrochloride) and the Novartis drug Femara (letrozole). The Taxotere generic is to be supplied by India's Dabur Pharma, which is expected to deliver its first thousand doses soon, at 1 percent of the Sanofi price. (Click here for more
PERTH, Australia - Local Thai drug makers are urging the Thai government to issue compulsory licenses for three patented cancer drugs, saying the licenses are legal and would benefit Thailand, the Bangkok Post reported
PERTH, Australia - A plan by Thailand's new Public Health Minister Chaiya Sasomsab to review the country's policy on compulsory licensing for four cancer drugs has stalled again after three ministry officials said the policy could not be revoked, the Bangkok Post reported Feb. 20